Literature DB >> 31061658

Overview of Extraintestinal Manifestations of Inflammatory Bowel Disease.

Millie D Long1.   

Abstract

Entities:  

Year:  2019        PMID： 31061658      PMCID： PMC6495412     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  6 in total

1.  Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort.

Authors:  Stephan R Vavricka; Lionel Brun; Pierluigi Ballabeni; Valérie Pittet; Bettina Mareike Prinz Vavricka; Jonas Zeitz; Gerhard Rogler; Alain M Schoepfer
Journal:  Am J Gastroenterol       Date:  2010-08-31       Impact factor: 10.864

2.  The Pathogenesis of Extraintestinal Manifestations: Implications for IBD Research, Diagnosis, and Therapy.

Authors:  C R H Hedin; S R Vavricka; A J Stagg; A Schoepfer; T Raine; L Puig; U Pleyer; A Navarini; A E van der Meulen-de Jong; J Maul; K Katsanos; A Kagramanova; T Greuter; Y González-Lama; F van Gaalen; P Ellul; J Burisch; D Bettenworth; M D Becker; G Bamias; F Rieder
Journal:  J Crohns Colitis       Date:  2019-04-26       Impact factor: 9.071

3.  Extraintestinal Manifestations of Pediatric Inflammatory Bowel Disease: Prevalence, Presentation, and Anti-TNF Treatment.

Authors:  Thomas Greuter; Fabio Bertoldo; Roman Rechner; Alex Straumann; Luc Biedermann; Jonas Zeitz; Benjamin Misselwitz; Michael Scharl; Gerhard Rogler; Ekaterina Safroneeva; Raja A R Ali; Christian Braegger; Klaas Heyland; Pascal Mueller; Andreas Nydegger; Laetitia-Marie Petit; Susanne Schibli; Raoul I Furlano; Johannes Spalinger; Michela Schäppi; Samuel Zamora; Florian Froehlich; Denise Herzog; Alain M Schoepfer; Stephan R Vavricka
Journal:  J Pediatr Gastroenterol Nutr       Date:  2017-08       Impact factor: 2.839

4.  Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study.

Authors:  Stephan R Vavricka; Martin Gubler; Claudine Gantenbein; Muriel Spoerri; Florian Froehlich; Frank Seibold; Marijana Protic; Pierre Michetti; Alex Straumann; Nicolas Fournier; Pascal Juillerat; Luc Biedermann; Jonas Zeitz; Benjamin Misselwitz; Michael Scharl; Henriette Heinrich; Christine N Manser; Ekaterina Safroneeva; Raja Affendi Raja Ali; Gerhard Rogler; Alain M Schoepfer; Thomas Greuter
Journal:  Inflamm Bowel Dis       Date:  2017-07       Impact factor: 5.325

5.  Primary sclerosing cholangitis in the Swiss Inflammatory Bowel Disease Cohort Study: prevalence, risk factors, and long-term follow-up.

Authors:  Montserrat Fraga; Nicolas Fournier; Ekaterina Safroneeva; Valérie Pittet; Sébastien Godat; Alex Straumann; Andreas Nydegger; Stephan R Vavricka; Darius Moradpour; Alain M Schoepfer
Journal:  Eur J Gastroenterol Hepatol       Date:  2017-01       Impact factor: 2.566

6.  Inflammatory Articular Disease in Patients with Inflammatory Bowel Disease: Result of the Swiss IBD Cohort Study.

Authors:  Saskia Ditisheim; Nicolas Fournier; Pascal Juillerat; Valerie Pittet; Pierre Michetti; Cem Gabay; Axel Finckh
Journal:  Inflamm Bowel Dis       Date:  2015-11       Impact factor: 5.325
  6 in total
  2 in total

1.  Extraintestinal manifestations at baseline, and the effect of tofacitinib, in patients with moderate to severe ulcerative colitis.

Authors:  David T Rubin; Walter Reinisch; Thomas Greuter; Paulo G Kotze; Marcia Pinheiro; Rajiv Mundayat; Eric Maller; Marc Fellmann; Nervin Lawendy; Irene Modesto; Stephan R Vavricka; Gary R Lichtenstein
Journal:  Therap Adv Gastroenterol       Date:  2021-05-16       Impact factor: 4.409

2.  Pain Severity and Vitamin D Deficiency in IBD Patients.

Authors:  Svein Oskar Frigstad; Marte Lie Høivik; Jørgen Jahnsen; Milada Cvancarova; Tore Grimstad; Ingrid Prytz Berset; Gert Huppertz-Hauss; Øistein Hovde; Tomm Bernklev; Bjørn Moum; Lars-Petter Jelsness-Jørgensen
Journal:  Nutrients       Date:  2019-12-20       Impact factor: 5.717
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.